Search Constraints
« Previous |
1 - 20 of 66
|
Next »
Search Results
Select an image to start the slideshow
A Statement
1 of 20
A Summary of the National Institutes of Health (USA) Guidelines for Recombinant DNA Research
2 of 20
Appendix C: Program of the International Conference on Recombinant DNA Molecules
3 of 20
Appendix D: Proposed Guidelines on Potential Biohazards Associated with Experiments Involving Genetically Altered Microorganisms
4 of 20
Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes
5 of 20
Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes
6 of 20
Appendix F: Cloned Eukaryotic DNA
7 of 20
Appendix F: Cloned Eukaryotic DNA
8 of 20
Appendix H: Provisional Statement of the Conference Proceedings
9 of 20
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
10 of 20
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
11 of 20
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
12 of 20
Appendix J: A Plausible Model for Monitoring Compliance with Containment Guidelines
13 of 20
David Baltimore speaking at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA
14 of 20
David Hogness speaking at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA
15 of 20
Interview with Dr. Maxine F. Singer [on recombinant DNA research and NIH]
16 of 20
Letter from Carolyn E. Kemp to Maxine Singer
17 of 20
Letter from Charles Warren and Barry Keene to Maxine Singer
18 of 20
Letter from David Baltimore to Fred C. Ikle
19 of 20
Letter from David S. Hogness to DeWitt Stetten, Jr
20 of 20